Johnson A J, Roehrig J T
Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, United States Department of Health and Human Services, Fort Collins, Colorado 80522, USA.
J Virol. 1999 Jan;73(1):783-6. doi: 10.1128/JVI.73.1.783-786.1999.
Several dengue (DEN) virus vaccines are in development; however, the lack of a reliable small animal model in which to test them is a major obstacle. Because evidence suggests that interferon (IFN) is involved in the human anti-DEN virus response, we tested mice deficient in their IFN functions as potential models. Intraperitoneally administered mouse-adapted DEN 2 virus was uniformly lethal in AG129 mice (which lack alpha/beta IFN and gamma IFN receptor genes), regardless of age. Immunized mice were protected from virus challenge, and survival times increased following passive transfer of anti-DEN polyclonal antibody. These results demonstrate that AG129 mice are a promising small animal model for DEN virus vaccine trials.
几种登革热(DEN)病毒疫苗正在研发中;然而,缺乏用于测试这些疫苗的可靠小动物模型是一个主要障碍。因为有证据表明干扰素(IFN)参与人体抗登革热病毒反应,所以我们测试了缺乏IFN功能的小鼠作为潜在模型。腹腔注射适应小鼠的DEN 2病毒对AG129小鼠(缺乏α/β干扰素和γ干扰素受体基因)具有一致的致死性,无论年龄大小。免疫小鼠可免受病毒攻击,并且在被动转移抗登革热多克隆抗体后存活时间延长。这些结果表明,AG129小鼠是用于登革热病毒疫苗试验的一种很有前景的小动物模型。